CAMG
WST icon

CWA Asset Management Group’s West Pharmaceutical WST Stock Holding History

CWA Asset Management Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$311K Buy
+867
New +$265K 0.01% 583
2026
Q1 		– Sell
-744
Closed -$205K – 749
2025
Q4 		$205K Sell
744
-478
-39% -$131K 0.01% 618
2025
Q3 		$321K Buy
1,222
+197
+19% +$47.9K 0.01% 547
2025
Q2 		$224K Buy
+1,025
New +$219K 0.01% 600
2025
Q1 		– Sell
-778
Closed -$255K – 630
2024
Q4 		$255K Buy
778
+67
+9% +$21.1K 0.01% 508
2024
Q3 		$213K Buy
+711
New +$218K 0.01% 546
2024
Q1 		$331K Buy
837
+126
+18% +$46.6K 0.02% 394
2023
Q4 		$250K Buy
+711
New +$252K 0.02% 371

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

CWA Asset Management Group's WST Position: Q2 2026 in Review

CWA Asset Management Group opened a new position in West Pharmaceutical (WST) in Q2 2026: 867 shares worth $311K. The stake represents 0.01% of the portfolio and ranks #583 among its holdings. This is a return to the name: CWA Asset Management Group previously reported a position in WST as recently as Q4 2025.

CWA Asset Management Group first reported a position in WST in Q4 2023 and has held it in 8 quarters since. The position peaked at $331K in Q1 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • CWA Asset Management Group held 867 shares of West Pharmaceutical worth $311K as of Q2 2026.
  • West Pharmaceutical was a new CWA Asset Management Group position in Q2 2026.
  • West Pharmaceutical made up 0.01% of CWA Asset Management Group's portfolio in Q2 2026, its #583 holding.
  • CWA Asset Management Group first reported a position in West Pharmaceutical in Q4 2023 and has held it in 8 quarters since.
  • CWA Asset Management Group's West Pharmaceutical position peaked at $331K in Q1 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on CWA Asset Management Group's 13F filing for Q2 2026, filed 14 Jul 2026.